Document is current
Any future updates will be listed below
-
Authors
Lee, Wei
Nagla, Ahmed
Wong, Aaron Bak Ong
Magann, Linda
Lovell, Melanie
Mantle, Edward
Reed, Kate
Aggarwal, Ghauri
Wong, Aaron K.
Pene, Chris
Allcroft, Peter
Crawford, Gregory B.
Michael, Natasha
-
Funding
Funding for this research was provided by:
Menarini Group
The University of Sydney
- License Information
-
More Information
Article History
Received: 3 November 2025
Accepted: 26 February 2026
First Online: 11 March 2026
Declarations
:
: GBC received an untied educational grant from Menarini in 2021 to conduct research on the beliefs and practices of Australian prescribers regarding breakthrough cancer pain management, as well as honoraria for a dinner meeting talk and roundtable discussions. ABW and WL received honoraria from Menarini for the roundtable meetings and related conference sponsorship. CP and GA received honorarium from Menarini for this roundtable discussion. NM was previously on the Advisory Board of Menarini Australia Ltd and Received Honorariums from Menarini Australia Ltd. Menarini Australia Ltd assisted with platform setup for the roundtable and reimbursed some participants’ travel and time; they had no role in participant selection, concept design, data analysis, or manuscript preparation.
: All participants provided written informed consent to participate in the roundtable discussions.
: All participants provided written informed consent to have the results published.
: In line with the National Statement on Ethical Conduct in Human Research (2023) by the National Health and Medical Research Council, the research did not require ethics approval as it was conducted using publicly available literature [ ].
